Russell Investments Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Russell Investments Group’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-63	Closed	-$255	–	3399
2023 Q4	$255	Buy	+63	New	+$192	﹤0.01%	3169

Russell Investments Group's THRX Position: Q1 2024 in Review

Russell Investments Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 63 shares — an estimated $255 sold.

Russell Investments Group first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $255 in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Russell Investments Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Russell Investments Group sold 63 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $255.
Russell Investments Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Russell Investments Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $255 in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.